Focus: DNA Script is a French biotech specializing in enzymatic DNA synthesis technology, operating at the platform/enabling technology stage rather than as a traditional therapeutic developer.
Profile data last refreshed 10h ago · AI intelligence enriched 3w ago
Best suited for scientists and commercialization professionals comfortable with pre-revenue biotech risk in exchange for equity upside and the chance to build a platform business from the ground up.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for DNA Script
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from DNA Script's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moBased on last 4 crawl cycles
Recent peer-reviewed publications with author affiliations at this company
Showing 5 of 8 publications